Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Carboxypeptidase E (CPE), also known as carboxypeptidase H or neurotrophic factor-α1 (CPE-NFα1), is a zinc-dependent metallocarboxypeptidase primarily involved in the processing and maturation of peptide hormones and neuropeptides. It functions by cleaving basic amino acids from the C-terminal end of peptide precursors, thereby generating their active forms. Beyond hormone processing, CPE plays critical roles in metabolic processes including glucose homeostasis, bone remodeling, fertility regulation, stress response modulation, learning/memory formation, mood/emotional responses. Dysfunctions are linked with obesity, diabetes mellitus type II, infertility, learning disabilities/cognitive impairment, and neurodegenerative diseases.
Cleaves C-terminal basic amino acids from peptide precursors
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Carboxypeptidase E (CPE).